SCHEMBL9703362

SCHEMBL9703362

COc1cc([S+](C)[O-])ccc1-c1nc2cc3c(cc2[nH]1)C(C)(C)CNC3=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 4/20 0.37
PDE3B Q13370 3/20 0.37
PDE3A Q14432 3/20 0.37
AMY1A P0DUB6 9/20 0.37
AURKA O14965 1/20 0.34
KDR P35968 1/20 0.34
PDE2A O00408 1/20 0.34
KDM4E B2RXH2 2/20 0.33
MEN1 O00255 1/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
CYP1A2 P05177 1/20 0.33
HPGD P15428 1/20 0.33
KMT2A Q03164 1/20 0.33
HSD17B10 Q99714 1/20 0.33
PDE4A P27815 1/20 0.33
PDE4B Q07343 1/20 0.33
PDE4C Q08493 1/20 0.33
PDE4D Q08499 1/20 0.33
PRKAG1 P54619 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9705366 0.86 TP53 (0.42) PDE5APDE3BPDE3AAMY1AAURKA
SCHEMBL10558256 0.85 AMY1A (0.39) PDE5APDE3BPDE3AAMY1APDE2A
SCHEMBL9383861 0.85 CDK4 (0.41) PDE5APDE3BPDE3AAMY1A
SCHEMBL9703428 0.85 PDE3B (0.41) PDE5APDE3BPDE3AAMY1AAURKA
SCHEMBL9703298 0.84 PDE5A (0.38) PDE5APDE3BPDE3AAMY1AAURKA
SCHEMBL9704386 0.81 PDE2A (0.39) PDE5APDE3BPDE3AAMY1AAURKA
SCHEMBL9703649 0.79 AMY1A (0.43) PDE5APDE3BPDE3AAMY1APDE2A
SCHEMBL10373752 0.78 PDE3B (0.48) PDE5APDE3BPDE3AAMY1AAURKA
SCHEMBL9703453 0.77 AMY1A (0.37) PDE5APDE3BPDE3AAMY1AAURKA
SCHEMBL10700489 0.77 NPC1 (0.49) PDE3BPDE3AAURKAKDRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5116843-A Anticoagulants, hypotensive agents and cardiovascular disorder BOEHRINGER MANNHEIM GMBH (DE) 1992-05-26 US disclosed
EP-0275888-A2 Tricyclic benzimidazoles, process for their preparation and use as medicaments Roche Diagnostics GmbH (DE) 1988-07-27 EP disclosed